Lakefront Biotherapeutics American Depositary Shares
LKFT
111 hedge funds and large institutions have $1.29B invested in Lakefront Biotherapeutics American Depositary Shares in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 20 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
45% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 20
16% more capital invested
Capital invested by funds: $1.11B → $1.29B (+$179M)
9% more funds holding
Funds holding: 102 → 111 (+9)
3% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 33
2.08% less ownership
Funds ownership: 15.72% → 13.65% (-2.1%)
59% less call options, than puts
Call options by funds: $15.2M | Put options by funds: $37.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$50M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$19M |
| 3 |
Jane Street
New York
|
+$8.38M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$8.25M |
| 5 |
Morgan Stanley
New York
|
+$6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$28M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$18.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.4M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$12.6M |
| 5 |
Sands Capital Management
Arlington,
Virginia
|
-$9.63M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Ameriprise
Minneapolis,
Minnesota
| – | -$329K | -2,552 | Closed |
|
|
QT
127
Quantamental Technologies
White Plains,
New York
| – | -$93.4K | -570 | -100% |
|
|
OIA
128
OneDigital Investment Advisors
Overland Park,
Kansas
| – | -$19K | -150 | Closed |
|
129
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$7K | -57 | Closed |
|
|
CIAS
130
Capital Investment Advisory Services
Raleigh,
North Carolina
| – | -$9K | -48 | Closed |
|
131
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | +$164 | +1 | New |
|
LKFT Hedge Fund Activity: Q3 2019 in Review
111 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q3 2019, worth a combined $1.29B — up 16% from $1.11B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new LKFT positions and 20 closed out — a net gain of 9 holders — while 34 added to existing stakes and 33 trimmed.
The largest buyer was BVF Inc, opening a new position worth an estimated $50M. The largest seller was Bank of New York Mellon, cutting an estimated $28M.
- 111 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q3 2019, up from 102 in Q2 2019.
- Funds reported $1.29B of Lakefront Biotherapeutics American Depositary Shares stock for Q3 2019, up 16% quarter-over-quarter.
- 29 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q3 2019 and 20 closed out, a net change of +9 holders.
- The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q3 2019 was BVF Inc, an estimated $50M added.
- The largest Lakefront Biotherapeutics American Depositary Shares seller in Q3 2019 was Bank of New York Mellon, an estimated $28M sold.
Based on aggregated 13F filings for Q3 2019.